Table 2 Mortality and morbidity results of patients in group 1 and group 2
Group 1 (< 65 years old) | Group 2 (≥ 65 years old) | p | |
|---|---|---|---|
Total hospital stay (days) median (range) | 22.0 (5–306) | 22.5 (6–157) | 0.925 |
ICU stay (days) median (range) | 2.0 (0–71) | 2.0 (1–101) | 0.629 |
HDU stay (days) median (range) | 3.0 (0–39) | 2.0 (0–39) | 0.831 |
Hospital death n (%) | 10 (2) | 4 (3) | 0.607 |
Complication grade n (%) | 0.644 | ||
0 | 88 (18) | 25 (20) | |
I | 19 (4) | 8 (6) | |
II | 166 (34) | 42 (34) | |
III | 125 (26) | 31 (25) | |
IV | 89 (18) | 18 (15) | |
Tumour-related OS median (months) (95 % CI) | 0.889 | ||
CRC (n = 184) | 27.0 (20.4–33.6) | 42.0 (30.1–53.3) | 0.130 |
PMP (n = 157) | MNR | MNR | 0.356 |
Mesothelioma (n = 53) | 62.0 (17.2–106.8) | 22.0 (5.5–38.5) | 0.186 |
Appendiceal cancer (n = 137) | 64.0 (55.4–72.6) | 43.0 (28.5–57.5) | 0.475 |
Others (n = 80) | 25.0 (16.8–33.2) | 24.0 (4.8–43.2) | 0.664 |